- Home
- / China Chemical & Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
China Chemical & Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
NT$8.6 B
FY, 2023
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|
| Revenue | 7.6B | 8.0B | 8.2B | 7.9B | 8.5B | 8.6B |
| Cost of goods sold | 4.5B | 4.7B | 4.9B | 4.8B | 5.1B | 5.1B |
| Gross profit | 3.1B | 3.3B | 3.3B | 3.3B | 3.4B | 3.5B |
| Gross profit margin, % | 40.8% | 40.6% | 40.9% | 40.3% | 40.8% | |
| Operating expense total | 2.5B | 2.6B | 2.6B | 2.5B | 2.7B | 2.9B |
| Depreciation and amortization | 255.9M | 257.5M | 265.2M | 277.5M | 291.8M | 314.3M |
| EBITDA | 605.2M | 723.9M | 895.4M | 942.5M | 874.9M | 752.5M |
| EBITDA margin, % | 9.1% | 10.9% | 11.9% | 10.3% | 8.8% | |
| EBIT | 444.4M | 467.4M | 634.8M | 661.1M | 597.8M | 439.2M |
| EBIT margin, % | 5.9% | 7.8% | 8.3% | 7.1% | 5.1% | |
| Interest income | 28.4M | 21.7M | 8.2M | 23.3M | 11.2M | 11.2M |
| Interest expense | 37.7M | 44.0M | 42.8M | 35.8M | 41.9M | 59.5M |
| Pre tax profit | 450.5M | 445.6M | 657.6M | 659.2M | 588.7M | 391.2M |
| Income tax expense | 83.5M | 60.7M | 98.1M | 142.9M | 109.4M | 67.6M |
| Net Income | 366.9M | 384.8M | 559.5M | 516.4M | 479.3M | 323.6M |